EFO1 inhibitors are a class of chemical compounds that specifically target and modulate the activity of the EFO1 (Embryonal Fyn-associated Substrate One) protein, a transcription factor involved in the regulation of gene expression during embryonic development and cellular differentiation. EFO1 is part of a larger family of transcription factors that interact with DNA to control the expression of specific genes, influencing various cellular processes such as cell growth, proliferation, and differentiation. The activity of EFO1 is crucial in early developmental stages, where it helps orchestrate the complex genetic programs that guide the formation of tissues and organs by regulating the expression of key developmental genes.
Inhibitors of EFO1 function by interfering with its ability to bind to DNA or by disrupting its interactions with other regulatory proteins and cofactors that are necessary for its transcriptional activity. These inhibitors may bind directly to the DNA-binding domain of EFO1, preventing it from attaching to the promoter regions of target genes, thereby blocking the transcription of those genes. Alternatively, some inhibitors might target the protein-protein interaction domains of EFO1, disrupting its ability to recruit or interact with other transcriptional machinery components, which are essential for the initiation and regulation of gene expression. By inhibiting EFO1, these compounds provide researchers with a tool to study the precise roles of this transcription factor in gene regulation and developmental biology. Understanding the effects of EFO1 inhibition can shed light on the molecular mechanisms that govern embryonic development and cellular differentiation, offering insights into how specific genes are regulated during these critical processes. This knowledge is fundamental to unraveling the complex networks of gene expression that drive the development and function of multicellular organisms.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, could potentially lead to a hyperacetylated chromatin state, thereby decreasing the transcriptional activity of the EFO1 gene locus. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine could cause hypomethylation of the EFO1 gene promoter, potentially resulting in the downregulation of EFO1 mRNA transcription. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $136.00 $492.00 | 13 | |
Garcinol exhibits inhibitory action against histone acetyltransferases, which may lead to a direct reduction in the acetyltransferase function of EFO1, hindering its enzymatic activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has been observed to downregulate the expression of specific genes; it may decrease EFO1 expression by inhibiting transcription factors or cofactors required for EFO1 gene transcription. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Anacardic Acid, by inhibiting histone acetyltransferase activity, could reduce the expression of EFO1 by preventing the acetylation that normally activates its gene transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may lead to changes in chromatin structure around the EFO1 gene, resulting in reduced transcriptional activity and consequently lower EFO1 expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram's inhibitory effect on acetyltransferases could extend to EFO1, leading to decreased expression by altering the acetylation pattern of proteins that govern EFO1's gene expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein, by inhibiting tyrosine kinases, could disrupt downstream signaling pathways that are crucial for the maintenance of EFO1 expression, thereby leading to its decreased expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin, as a flavonoid with various biological activities, could downregulate EFO1 expression by interfering with specific transcription factors necessary for the expression of the EFO1 gene. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Caffeine might decrease EFO1 expression by altering intracellular cAMP concentrations, which are imperative for the transcriptional regulation of various genes, including EFO1. | ||||||